XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Leases (Tables)
12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Summary of the Components of Net Lease Cost
The following table is a summary of the components of net lease cost for the years ended December 31, 2022, 2021 and 2020:
In millions202220212020
Operating lease cost$2,579 $2,633 $2,670 
Finance lease cost:
Amortization of right-of-use assets79 62 56 
Interest on lease liabilities68 62 58 
Total finance lease costs147 124 114 
Short-term lease costs27 25 22 
Variable lease costs610 604 599 
Less: sublease income(61)(59)(55)
Net lease cost$3,302 $3,327 $3,350 

Supplemental cash flow information related to leases for the years ended December 31, 2022, 2021 and 2020 were as follows:
In millions202220212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows paid for operating leases$2,689 $2,714 $2,724 
Operating cash flows paid for interest portion of finance leases68 62 58 
Financing cash flows paid for principal portion of finance leases62 50 34 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases591 1,254 1,679 
Finance leases232 278 313 
Supplemental Balance Sheet Information
Supplemental balance sheet information related to leases as of December 31, 2022 and 2021 is as follows:
In millions, except remaining lease term and discount rate20222021
Operating leases:
Operating lease right-of-use assets (1)
$17,928$19,122
Current portion of operating lease liabilities$1,699$1,646
Long-term operating lease liabilities16,83918,177
Total operating lease liabilities (2)
$18,538$19,823
Finance leases:
Property and equipment, gross$1,608$1,375
Accumulated depreciation(284)(188)
Property and equipment, net$1,324$1,187
Current portion of long-term debt$59$50
Long-term debt1,4061,250
Total finance lease liabilities$1,465$1,300
Weighted average remaining lease term (in years)
Operating leases12.212.8
Finance leases19.420.0
Weighted average discount rate
Operating leases4.4 %4.4 %
Finance leases4.9 %5.0 %
_____________________________________________
(1)Includes operating lease right-of-use assets of $56 million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 ‘‘Acquisitions, Divestitures and Asset Sales’’ for additional information.
(2)Includes current portion of operating lease liabilities of $21 million and long-term operating lease liabilities of $39 million which have been accounted for as liabilities held for sale and are included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 ‘‘Acquisitions, Divestitures and Asset Sales’’ for additional information.
Maturities of Operating Lease Liabilities
The following table summarizes the maturity of lease liabilities under finance and operating leases as of December 31, 2022:
In millionsFinance
Leases
Operating
Leases
(1)
Total
2023$139 $2,685 $2,824 
2024130 2,499 2,629 
2025128 2,313 2,441 
2026127 2,142 2,269 
2027124 1,989 2,113 
Thereafter1,640 12,411 14,051 
Total lease payments (2)
2,288 24,039 26,327 
Less: imputed interest(823)(5,501)(6,324)
Total lease liabilities$1,465 $18,538 $20,003 
_____________________________________________
(1)Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.
(2)The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.
Maturities of Finance Lease Liabilities
The following table summarizes the maturity of lease liabilities under finance and operating leases as of December 31, 2022:
In millionsFinance
Leases
Operating
Leases
(1)
Total
2023$139 $2,685 $2,824 
2024130 2,499 2,629 
2025128 2,313 2,441 
2026127 2,142 2,269 
2027124 1,989 2,113 
Thereafter1,640 12,411 14,051 
Total lease payments (2)
2,288 24,039 26,327 
Less: imputed interest(823)(5,501)(6,324)
Total lease liabilities$1,465 $18,538 $20,003 
_____________________________________________
(1)Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.
(2)The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.